CXCR4 and neoplasm: The tumor-to-muscle ratio of 211At-CXCR4 mAb uptake was highest (8.51 ±6.14) at 6 h, at this time point, the tumor-to-muscle ratio of 125I-CXCR4 mAb uptake was 5.51 ± 0.74.